Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Current Leases: 2019-2025

Historic Current Leases for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to $102,000.

  • Abeona Therapeutics' Current Leases fell 90.35% to $102,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $102,000, marking a year-over-year decrease of 90.35%. This contributed to the annual value of $823,000 for FY2024, which is 17.54% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Current Leases of $102,000 as of Q3 2025, which was down 81.01% from $537,000 recorded in Q2 2025.
  • Abeona Therapeutics' Current Leases' 5-year high stood at $1.8 million during Q1 2022, with a 5-year trough of $102,000 in Q3 2025.
  • Its 3-year average for Current Leases is $1.1 million, with a median of $1.0 million in 2024.
  • Per our database at Business Quant, Abeona Therapeutics' Current Leases increased by 12.21% in 2024 and then tumbled by 90.35% in 2025.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Current Leases stood at $1.8 million in 2021, then decreased by 2.48% to $1.8 million in 2022, then plummeted by 43.71% to $998,000 in 2023, then decreased by 17.54% to $823,000 in 2024, then plummeted by 90.35% to $102,000 in 2025.
  • Its Current Leases stands at $102,000 for Q3 2025, versus $537,000 for Q2 2025 and $613,000 for Q1 2025.